Neumora Therapeutics, Inc. Common StockNMRANASDAQ
LOADING
|||
Operating Income Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
-6.77%
↑ 86% above average
Average (19q)
-47.83%
Historical baseline
Range
High:85.10%
Low:-935.65%
Volatility
-2134.1%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -6.77% |
| Q2 2025 | 23.82% |
| Q1 2025 | -12.74% |
| Q4 2024 | 17.91% |
| Q3 2024 | -20.09% |
| Q2 2024 | -6.24% |
| Q1 2024 | -19.91% |
| Q4 2023 | 11.90% |
| Q3 2023 | -35.19% |
| Q2 2023 | -7.39% |
| Q1 2023 | -27.51% |
| Q4 2022 | -0.38% |
| Q3 2022 | 2.27% |
| Q2 2022 | 27.57% |
| Q1 2022 | -62.87% |
| Q4 2021 | 85.10% |
| Q3 2021 | -935.65% |
| Q2 2021 | -11.36% |
| Q1 2021 | 20.91% |
| Q4 2020 | 0.00% |